Digital pathology market size worth USD 1719.31M by 2030

The global digital pathology market is projected to grow at a CAGR of 13.64% from 2022 to 2030, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 628.54 Million in 2021 and is expected to reach USD 1719.31 Million by the end of the forecast period.

Global digital pathology market: Transforming healthcare through technological advancements amidst challenges
The global digital pathology market, a pivotal segment within the field of pathology, is poised for remarkable expansion fueled by a convergence of key market drivers, despite formidable challenges. A recent market analysis has shed light on the industry’s growth trajectory, offering valuable insights into its outlook, opportunities, and key players.

Digital pathology market opportunities and challenges:
Despite its promising growth, the Global Digital Pathology Market faces certain challenges. The high cost associated with digital pathology systems may pose constraints on market expansion. Moreover, the shortage of adequately trained professionals presents a multifaceted challenge that requires careful consideration during the forecast period. However, the introduction of cost-effective scanning solutions promises lucrative opportunities for market expansion.

Digital pathology market key players:
Leading players in the global digital pathology market include 3DHISTECH, Hamamatsu Photonics, Leica Biosystems, Koninklijke Philips, Apollo Enterprise Imaging, XIFIN, Ventana Medical Systems, Visiopharm, Corista, and Huron Digital Pathology. Their innovative solutions and strategic initiatives have contributed significantly to the industry’s growth.

The North American region currently commands the largest market share, driven by early adoption and the presence of numerous vendors offering cutting-edge digital pathology solutions.

As the Global Digital Pathology Market continues to evolve and overcome challenges, it stands poised for remarkable growth, providing valuable advancements in the field of pathology. Verified Market Research